T3X
4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide
Find entries where: T3X
is present as a standalone ligand in 5 entries
Chemical Component Summary | |
---|---|
Name | 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide |
Identifiers | 4-methyl-~{N}-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1~{H}-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide |
Formula | C29 H27 F3 N6 O |
Molecular Weight | 532.559 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1ccc(cc1C#Cc2cc3cn[nH]c3nc2)C(=O)Nc4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C |
InChI | InChI=1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36) |
InChIKey | TZKBVRDEOITLRB-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 66 |
Chiral Atom Count | 0 |
Bond Count | 70 |
Aromatic Bond Count | 22 |
Drug Info: DrugBank
DrugBank ID | DB16185 |
---|---|
Name | HQP1351 |
Groups | investigational |
Description | HQP1351 is under investigation in clinical trial NCT03883100 (A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation). |
Synonyms |
|
Categories |
|
CAS number | 1257628-77-5 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL2316582 |
PubChem | 51038269 |
ChEMBL | CHEMBL2316582 |